Echelon Partners with Trinity Biotech's Liquid Cooling Spin-off Trinovium for AI Data Center Solutions

Irish data center firm Echelon Data Centres has entered into a strategic collaboration agreement with Trinovium, a newly launched liquid cooling subsidiary of Nasdaq-listed biotech company Trinity Biotech, to develop advanced cooling technologies for AI and high-density computing environments. The partnership marks an early commercial win for Trinovium, which was spun out earlier this year to leverage Trinity's expertise in ultra-high-purity fluid manufacturing.

Under the agreement, the two companies will jointly develop and refine liquid cooling technologies informed by the requirements of the hyperscale and AI infrastructure Echelon is building across its European portfolio. Development activities are expected to "commence imminently," with initial focus areas including direct-to-chip cooling fluids, thermal management systems, and modular liquid cooling solutions optimized for AI and high-performance computing deployments.

The collaboration is significant as data center operators increasingly turn to liquid cooling to manage the extreme heat densities generated by AI workloads, which traditional air cooling can no longer handle efficiently. For Echelon, which counts Starwood as its owner and has eight campuses in its pipeline across Europe totaling 1.2GW of capacity, the partnership provides a pathway to integrate next-generation cooling directly into its design and construction processes. Approximately 400MW of that capacity is already operational or under development, with sites across Ireland, the UK, Spain, and Italy.

Niall Molloy, CEO of Echelon Data Centres, said: "This collaboration brings together Trinovium's expertise in fluid science and analytics with our experience of developing hyperscale infrastructure. It gives us an opportunity to develop and refine technologies specifically around the requirements of the next generation of AI data centers."

Trinovium was launched by Trinity Biotech earlier this year, aiming to apply the parent company's capabilities in ultra-high-purity fluid production and analytical technologies to develop a new dielectric fluid along with a fluid health and system intelligence platform. John Gillard, CEO of Trinity Biotech, added: "By combining Trinovium's capabilities in high-performance fluid design, precision manufacturing and advanced analytics with Echelon's hyperscale data center expertise, we believe we can accelerate the development of innovative liquid cooling solutions designed specifically for the next generation of AI infrastructure."

Industry analysts note that the deal reflects a broader trend of specialized fluid science companies entering the data center cooling market, as operators seek more efficient and reliable thermal management solutions to support the rapid scaling of AI compute. The partnership also underscores the growing importance of collaboration between infrastructure developers and technology innovators in addressing the physical challenges of AI deployment.